CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Palliative cancer care - nausea & vomiting - Management
Levomepromazine (at end of life)
Age from 16 years onwards
Levomepromazine sc inj: 6.25mg repeat after 1 hour if needed
Levomepromazine 25mg/1ml solution for injection ampoules
FOR SUBCUTANEOUS INJECTION. Give 0.25ml (6.25mg), repeat after 1 hour if needed.
Supply 1 1ml ampoule.
Levomepromazine subcutaneous infusion: give 12.5-25mg over 24 hours
Levomepromazine 25mg/1ml solution for injection ampoules
FOR CONTINUOUS SUBCUTANEOUS INFUSION. Give 0.5ml (12.5mg) to 1ml (25mg) over 24 hours via a syringe driver.
Supply 3 1ml ampoules.
© NHS Institute for Innovation and Improvement